arrow
施

施军平 (Junping Shi)

the affiliated hospital of hangzhou normal university教授
H指数:36
被引数:4,974

个人简介

"施军平,医学博士,主任中医师,教授(博士生导师)"

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Noninvasive Detection of MASH and Fibrotic Burden Using Ultrasound-Derived LIID and LSM in MASLD: A Multicenter Study

采用超声衍生的LIID和LSM对MASLD进行MASH和纤维化负担的无创检测:一项多中心研究

2026-09-070
PRE
Salidroside alleviates metabolic dysfunction-associated steatohepatitis-induced fibrosis by regulating PI3K/AKT/mTOR pathway-mediated hepatocyte mitophagy

沙棘多糖通过调控PI3K/AKT/mTOR通路介导的肝细胞线粒体自噬,缓解代谢功能障碍相关脂肪性肝炎诱导的纤维化

2026-07-010
PRE
Cardiovascular-kidney-metabolic (CKM) syndrome is associated with increased mortality in individuals with metabolic dysfunction-associated steatotic liver disease (MASLD)

心血管-肾脏-代谢(CKM)综合征与代谢功能障碍相关脂肪性肝病(MASLD)患者死亡率增加相关。

2025-11-210
OAAI
Integrative multiomic analysis identifies distinct molecular subtypes of NAFLD in a Chinese population
2024-11-062
PRE
Machine Learning-Based Models for Advanced Fibrosis and Cirrhosis Diagnosis in Chronic Hepatitis B Patients With Hepatic Steatosis

基于机器学习的慢性乙型肝炎伴肝脂肪变性患者晚期纤维化和肝硬化诊断模型

2024-11-010
PRE
Metabolic-associated fatty liver disease is less effective in predicting mortality than non-alcoholic fatty liver disease and metabolic dysfunction-associated steatotic liver disease: Letter to the editor on Prognosis of biopsy-confirmed metabolic dysfunction-associated steatotic liver disease: A sub-analysis of the CLIONE study

代谢相关的脂肪肝疾病在预测死亡率方面不如非酒精性脂肪肝疾病和代谢功能障碍相关的脂肪变性肝病有效: 致活检预后编辑的信-确认代谢功能障碍相关的脂肪变性肝病: cllione研究的子分析

2024-10-010
OAAI